Propranolol enhanced adipogenesis instead of induction of apoptosis of hemangiomas stem cells

Xiaorong Ma; Tinghui Zhao; Tianxiang Ouyang; Shujia Xin; Yueting Ma; Mengling Chang
July 2014
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p3809
Academic Journal
No abstract available.


Related Articles

  • El propranolol revoluciona el tratamiento de los hemangiomas en la infancia. Sevilla, Enrique Berdión; Viel, Valia Hernández // MEDISAN;2013, Vol. 17 Issue 7, p2069 

    The use of propranolol as a treatment option to cure or mitigate the hemangiomas in children was briefly reported. Although the mechanism by which the drug acts in these benign tumors is not very well-known, it is thought that it can be related to the control of cellular hypoxia, induction of...

  • Infantile Hemangiomas.  // Current Medical Literature: Dermatology;2010, Vol. 15 Issue 4, p103 

    The article focuses on studies relates to infantile hemangiomas (IH). One study examined the mechanism of action of propranolol in vasoconstriction, inhibition of angiogenesis, and induction of apoptosis in the treatment of IH. Researchers discussed pediatric patients who developed symptomatic...

  • Effect of propranolol on apoptosis and VEGF, bFGF expression of hemangioma -- derived stem cells. MAI Hua-ming; ZHENG Jia-wei; ZHANG Ling; WANG Yan-an; QIN Zhong-ping; LI Ke-lei; YUAN Wei-en; ZHENG Rui-yuan // China Journal of Oral & Maxillofacial Surgery;Jul2013, Vol. 11 Issue 4, p287 

    PURPOSE: Propranolol was found by chance very effective in treating hemangioma, yet the therapeutic mechanism remain unclear. This study was aimed to investigate the therapeutic mechanism of propranolol on hemangioma. METHODS: The plasma propranolol concentrations at 2,6,10,24 h were assayed by...

  • Mesenchymal Stem Cells in Infantile Hemangioma Reside in the Perivascular Region. Yuan, Si-Ming; Chen, Rong-Liang; Shen, Wei-Min; Chen, Hai-Ni; Zhou, Xiao-Jun // Pediatric & Developmental Pathology;Jan/Feb2012, Vol. 15 Issue 1, p5 

    Infantile hemangioma grows quickly in the first year of life and regresses slowly to fibrofatty tissue during childhood; mesenchymal stem cells (MSCs) have been reported to contribute to this adipogenesis. Recent studies have shown the perivascular origin of MSCs in multiple organs. We...

  • Role of propranolol in hemangiomas. Gajbhiye, Vishal; Nath, Sasanka; Chatterjee, Souvik; De, Avidip; Ghosh, Dipak; Das, Sukanta Kumar // Journal of Indian Association of Pediatric Surgeons;Oct-Dec2011, Vol. 16 Issue 4, p173 

    A letter to the editor is presented regarding propranolol's role in hemangiomas.

  • Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients. Albiñana, Virginia; Gómez de las Heras, Karina Villar; Serrano-Heras, Gemma; Segura, Tomás; Perona-Moratalla, Ana Belén; Mota-Pérez, Mercedes; de Campos, José María; Botella, Luisa María; Villar Gómez de Las Heras, Karina // Orphanet Journal of Rare Diseases;9/23/2015, Vol. 10 Issue 1, p1 

    Background: Von Hippel-Lindau (VHL) disease is a rare oncological disease with an incidence of 1:36,000, and is characterized by the growth of different types of tumors: hemangioblastomas in the central nervous system (CNS) and retina, renal carcinoma, pheochromocytomas, pancreatic...

  • Enhancement of adipogenic and osteogenic differentiation of human bone-marrow-derived mesenchymal stem cells by supplementation with umbilical cord blood serum. Tekkatte, Chandana; Vidyasekar, Prasanna; Kapadia, Nand; Verma, Rama // Cell & Tissue Research;Feb2012, Vol. 347 Issue 2, p383 

    Umbilical cord blood serum (UCBS) is a promising replacement for animal sera for the culture of human mesenchymal stem cells (hMSC), the unique serum composition of UCBS appearing to have variable effects on their proliferation and differentiation. Conditioning UCBS with methods such as charcoal...

  • Propranolol as a Novel Adjunctive Treatment for Head and Neck Squamous Cell Carcinoma. Wolter, Nikolaus E.; Wolter, Jennifer K.; Enepekides, Danny J.; Irwin, Meredith S. // Journal of Otolaryngology -- Head & Neck Surgery;Oct2012, Vol. 41 Issue 5, p334 

    Objective: To investigate propranolol as a novel treatment for head and neck squamous cell carcinoma (HNSCC) in vitro. Methods: HNSCC cell lines were cultured and treated with propranolol alone and in combination with cisplatin or γ-irradiation. The alamarBlue assay was performed to assess...

  • Propranolol Suppresses Cobalt Chloride-Induced Hypoxic Proliferation in Human Umbilical Vein Endothelial Cells in vitro. Wei, Li; Li, Li; Zhang, Bin; Ma, Lin // Pharmacology;Jan2019, Vol. 103 Issue 1/2, p61 

    Background/Aims: To investigate the effect of propranolol on cobalt chloride (CoCl2)-induced hypoxic proliferation in human umbilical vein endothelial cells (HUVECs). Methods: CoCl2 was administrated to HUVECs to mimic hypoxic proliferation in infantile hemangioma. The proliferation of HUVECs...

  • Rapamycin Suppresses Self-Renewal and Vasculogenic Potential of Stem Cells Isolated from Infantile Hemangioma. Greenberger, Shoshana; Yuan, Siming; Walsh, Logan A; Boscolo, Elisa; Kang, Kyu-Tae; Matthews, Benjamin; Mulliken, John B; Bischoff, Joyce // Journal of Investigative Dermatology;Dec2011, Vol. 131 Issue 12, p2467 

    Infantile hemangioma (IH) is a common childhood vascular tumor. Although benign, some hemangiomas cause deformation and destruction of features or endanger life. The current treatments, corticosteroid or propranolol, are administered for several months and can have adverse effects on the infant....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics